# Fidelity Select Biotechnology Pt (FBIOX): Mutual Fund Facts & Distributions > Markdown mirror of https://www.dividenddata.com/funds/fbiox for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice. - Issuer: Fidelity · Asset class: Equity - Strategy: Thematic · Inception: 1985-12-16 The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-di... ## Key Facts | Metric | Value | |---|---| | Price | $27.93 | | Expense Ratio | 0.62% | | Assets Under Management | $5.88B | | NAV | $27.93 | | Holdings Count | — | | Distribution Yield (TTM) | 5.81% | | Annual Distribution (TTM) | $1.62 /share | | Distribution Frequency | Semi-Annual | | 52-Week Range | $23.24 – $31.72 | | Beta | 0.70 | ## Latest Distribution - Amount: $1.0630 /share - Ex-date: 2026-04-10 - Pay date: 2026-04-13 ## Frequently Asked Questions ### What does FBIOX invest in? The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified. ### What is the expense ratio of FBIOX? Fidelity Select Biotechnology Pt (FBIOX) charges an expense ratio of 0.62%. This is the annual fee deducted from fund assets to cover management and operations. ### How big is FBIOX? Fidelity Select Biotechnology Pt (FBIOX) manages $5.88B in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure. Funds below ~$50M are at higher risk of liquidation. ### Is FBIOX actively managed or an index fund? FBIOX's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy. ### When was FBIOX launched? Fidelity Select Biotechnology Pt (FBIOX) launched in December 1985 and is managed by Fidelity. ### How has FBIOX performed? FBIOX's total return (price change plus reinvested distributions) is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon. ### Does FBIOX pay a dividend? Fidelity Select Biotechnology Pt (FBIOX) currently distributes little or no income. Trailing-twelve-month yield is 5.81%. Investors looking for income should consider income-focused alternatives. See the Peers tab. ### How often does FBIOX pay dividends? Fidelity Select Biotechnology Pt pays dividends Semi-Annual. Each ex-dividend date, record date, and payment date is listed in the dividend history table on this page. ### What is FBIOX's dividend yield? FBIOX's trailing-twelve-month yield is 5.81%, calculated from the sum of dividends over the past year divided by the current price. ### When is FBIOX's next ex-dividend date? The most recently announced ex-dividend date for FBIOX was 2026-04-10. The next ex-date typically follows Semi-Annual; once announced it appears at the top of the dividend history table on this page. ### How much will FBIOX's expense ratio cost me over 30 years? On a $10,000 investment compounding at 7% gross return, a 0.62% expense ratio quietly compounds against your balance every year. The Fee Compounding Forecast card above projects the dollar drag for any holding period and assumption you pick. The typical result for a 1.0% expense ratio on a 30-year hold is roughly 25% of the final balance lost to fees. ### How does FBIOX charge its expense ratio? The expense ratio is deducted in tiny daily slices from FBIOX's net asset value (NAV). You never see a bill. The price quoted on every exchange is already net of fees. There's no "fee day" to avoid; the cost is continuous and built into the trading price. ### Why does FBIOX cost more than a fund like VOO? FBIOX's strategy (current expense ratio 0.62%) is different from a broad-market index tracker like VOO, so its fee belongs to a different cohort. The Cost Verdict card above shows you where FBIOX sits within its own category, which is the comparison that actually matters. ### Are there cheaper alternatives to FBIOX? The Lower-Fee Alternatives card above lists mutual funds following the same investment strategy as FBIOX (0.62%) but at a lower expense ratio. Each row shows the fee gap, the peer's AUM as a liquidity sanity-check, and a direct link to that fund's analysis page. Cheaper price doesn't automatically mean better. Verify the peer holds what you actually want. ## More on Dividend Data - Overview (HTML): https://www.dividenddata.com/funds/fbiox - Distribution history: https://www.dividenddata.com/funds/fbiox/dividend - Holdings & diversification: https://www.dividenddata.com/funds/fbiox/diversification - Fees & cheaper alternatives: https://www.dividenddata.com/funds/fbiox/expenses - Peer comparison: https://www.dividenddata.com/funds/fbiox/peers Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.